首页 > 最新文献

Nutrition Metabolism and Cardiovascular Diseases最新文献

英文 中文
Sugar-sweetened beverages, low/no-calorie beverages, fruit juices intake and risks of metabolic syndrome in adults: The SWEET project. 成人含糖饮料、低热量/无热量饮料、果汁的摄入量与代谢综合征的风险:SWEET 项目。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-18 DOI: 10.1016/j.numecd.2024.09.014
Novita D Naomi, Elske M Brouwer-Brolsma, Marion E C Buso, Sabita S Soedamah-Muthu, Christina Mavrogianni, Joanne A Harrold, Jason C G Halford, Anne Raben, Johanna M Geleijnse, Yannis Manios, Edith J M Feskens

Background and aims: Metabolic syndrome (MetS) is an important determinant of cardiometabolic disease development, with excessive sugar intake as one of the key modifiable risk factors. However, evidence on the association between sugar-sweetened beverages (SSB), their replacement by low/no caloric beverages (LNCB), and MetS development is still limited.

Methods and results: Data from participants' of Lifelines (n = 58 220), NQPlus (n = 1094) and Feel4Diabetes (n = 342) were prospectively analysed. Dose-response associations were investigated using restricted cubic spline analyses (Lifelines). Cox proportional hazard regression analysis with robust variance was used to quantify associations between intakes of SSB, fruit juices (FJ) and LNCB and MetS incidence; data were pooled using random-effects models. Associations were adjusted for demographic, lifestyle and other dietary factors. In Lifelines, NQPlus, and Feel4Diabetes, 3853 (7 %), 47 (4 %), and 39 (11 %) participants developed MetS, respectively. Pooled analyses showed that each additional serving of SSB was associated with a 6 % higher risk of MetS (95%CI 1.02-1.10). A J-shaped association was observed for FJ and MetS, with a significant inverse association at moderate intake levels (IPR 0.89, 95 % CI 0.82-0.96). LNCB intake was not associated with MetS (IPR 1.59, 95%CI 0.74-2.43), but findings across studies were inconsistent (I2 94 %, p-value <0.01). Replacing SSB with FJ or LNCB did not show any associations with MetS incidence.

Conclusion: SSB intake was adversely associated with MetS incidence. A J-shaped association was observed between FJ and MetS. For LNCB, results were inconsistent across studies and therefore findings must be interpreted cautiously.

背景和目的:代谢综合征(MetS)是心血管代谢疾病发展的重要决定因素,而过量摄入糖是可改变的关键风险因素之一。然而,关于含糖饮料(SSB)、用低热量/无热量饮料(LNCB)替代含糖饮料与代谢综合征发展之间的关系的证据仍然有限:前瞻性地分析了 Lifelines(n = 58 220)、NQPlus(n = 1094)和 Feel4Diabetes(n = 342)参与者的数据。使用限制性立方样条分析(Lifelines)研究剂量-反应关系。采用稳健方差的 Cox 比例危险回归分析来量化 SSB、果汁 (FJ) 和 LNCB 的摄入量与 MetS 发病率之间的关联;采用随机效应模型对数据进行汇总。相关性已根据人口统计学、生活方式和其他饮食因素进行了调整。在 Lifelines、NQPlus 和 Feel4Diabetes 中,分别有 3853 人(7%)、47 人(4%)和 39 人(11%)患上 MetS。汇总分析表明,每增加一份 SSB,MetS 风险就会增加 6%(95%CI 1.02-1.10)。FJ与MetS呈 "J "形关联,在中等摄入水平时,两者呈显著的反向关联(IPR 0.89,95% CI 0.82-0.96)。LNCB 摄入量与 MetS 无关(IPR 1.59,95%CI 0.74-2.43),但各研究结果不一致(I2 94%,P 值 结论:SSB的摄入量与MetS的发病率呈负相关。FJ与MetS之间呈 "J "形关系。对于 LNCB,各研究的结果不一致,因此必须谨慎解释研究结果。
{"title":"Sugar-sweetened beverages, low/no-calorie beverages, fruit juices intake and risks of metabolic syndrome in adults: The SWEET project.","authors":"Novita D Naomi, Elske M Brouwer-Brolsma, Marion E C Buso, Sabita S Soedamah-Muthu, Christina Mavrogianni, Joanne A Harrold, Jason C G Halford, Anne Raben, Johanna M Geleijnse, Yannis Manios, Edith J M Feskens","doi":"10.1016/j.numecd.2024.09.014","DOIUrl":"https://doi.org/10.1016/j.numecd.2024.09.014","url":null,"abstract":"<p><strong>Background and aims: </strong>Metabolic syndrome (MetS) is an important determinant of cardiometabolic disease development, with excessive sugar intake as one of the key modifiable risk factors. However, evidence on the association between sugar-sweetened beverages (SSB), their replacement by low/no caloric beverages (LNCB), and MetS development is still limited.</p><p><strong>Methods and results: </strong>Data from participants' of Lifelines (n = 58 220), NQPlus (n = 1094) and Feel4Diabetes (n = 342) were prospectively analysed. Dose-response associations were investigated using restricted cubic spline analyses (Lifelines). Cox proportional hazard regression analysis with robust variance was used to quantify associations between intakes of SSB, fruit juices (FJ) and LNCB and MetS incidence; data were pooled using random-effects models. Associations were adjusted for demographic, lifestyle and other dietary factors. In Lifelines, NQPlus, and Feel4Diabetes, 3853 (7 %), 47 (4 %), and 39 (11 %) participants developed MetS, respectively. Pooled analyses showed that each additional serving of SSB was associated with a 6 % higher risk of MetS (95%CI 1.02-1.10). A J-shaped association was observed for FJ and MetS, with a significant inverse association at moderate intake levels (IPR 0.89, 95 % CI 0.82-0.96). LNCB intake was not associated with MetS (IPR 1.59, 95%CI 0.74-2.43), but findings across studies were inconsistent (I<sup>2</sup> 94 %, p-value <0.01). Replacing SSB with FJ or LNCB did not show any associations with MetS incidence.</p><p><strong>Conclusion: </strong>SSB intake was adversely associated with MetS incidence. A J-shaped association was observed between FJ and MetS. For LNCB, results were inconsistent across studies and therefore findings must be interpreted cautiously.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-processed food, genetic risk, and the risk of cardiometabolic diseases and cardiometabolic multimorbidity: A prospective study 超加工食品、遗传风险与心血管代谢疾病和心血管代谢多病风险:一项前瞻性研究。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-17 DOI: 10.1016/j.numecd.2024.09.011
Jing Wang , Tingting Chen , Wenmin Zhu , Ziwei Shi , Xiaolong Yan , Zhiqun Lei , Qi Wang

Background and aims

This study aims to evaluate the impact of ultra-processed food (UPF) on type 2 diabetes (T2D), cardiovascular disease (CVD), hypertension, and cardiometabolic multimorbidity (CMM), and to explore the role of genetic susceptibility in these associations.

Methods and results

90 631 participants from the UK Biobank were included (collected between 2006 and 2010). The outcomes assessed included T2D, CVD, hypertension and CMM. The Cox proportional hazards model was used to evaluate their associations and the potential modification by genetic risk, which was estimated using the polygenic risk score (PRS). Participants with high UPF consumption had a higher risk of T2D, CVD, and CMM, with the adjusted hazard ratio (HR) of 1.36 (95 % confidence interval [CI]: 1.15, 1.61), 1.13 (95%CI: 1.03, 1.23), and 1.14 (95%CI: 1.05, 1.24), respectively. Those with high UPF consumption and high PRS for T2D, CVD, and hypertension had the highest risk of T2D (HR: 4.01; 95%CI: 2.83, 5.69), CVD (HR: 2.18; 95%CI: 1.86, 2.56), and hypertension (HR: 1.79; 95%CI: 1.61, 1.99), respectively. In participants with one cardiometabolic disease (CMD), those with high UPF consumption and high PRST2D or PRSCVD had the highest risk of developing CMM. A significant additive interaction was observed between PRST2D and UPF consumption on the risk of T2D.

Conclusion

Our study underscored the importance of identifying individuals with high UPF consumption for targeted dietary interventions to mitigate the risk of CMDs and CMM, particularly among those with a high genetic risk of CMDs.
背景和目的:本研究旨在评估超加工食品(UPF)对2型糖尿病(T2D)、心血管疾病(CVD)、高血压和心脏代谢多病症(CMM)的影响,并探讨遗传易感性在这些关联中的作用:研究纳入了英国生物库中的 90 631 名参与者(收集时间为 2006 年至 2010 年)。评估的结果包括T2D、心血管疾病、高血压和CMM。采用 Cox 比例危险模型评估这些结果之间的关联以及遗传风险对结果的潜在影响,遗传风险是通过多基因风险评分(PRS)估算出来的。UPF消耗量高的参与者罹患T2D、心血管疾病和CMM的风险较高,调整后的危险比(HR)分别为1.36(95%置信区间[CI]:1.15,1.61)、1.13(95%CI:1.03,1.23)和1.14(95%CI:1.05,1.24)。UPF消耗量高且T2D、心血管疾病和高血压PRS高的人患T2D(HR:4.01;95%CI:2.83,5.69)、心血管疾病(HR:2.18;95%CI:1.86,2.56)和高血压(HR:1.79;95%CI:1.61,1.99)的风险分别最高。在患有一种心脏代谢疾病(CMD)的参与者中,UPF消耗量高、PRST2D或PRSCVD高的人患CMM的风险最高。PRST2D和UPF摄入量对T2D风险有明显的叠加作用:我们的研究强调了识别UPF消耗量高的个体进行有针对性的膳食干预以降低CMD和CMM风险的重要性,尤其是在CMD遗传风险高的人群中。
{"title":"Ultra-processed food, genetic risk, and the risk of cardiometabolic diseases and cardiometabolic multimorbidity: A prospective study","authors":"Jing Wang ,&nbsp;Tingting Chen ,&nbsp;Wenmin Zhu ,&nbsp;Ziwei Shi ,&nbsp;Xiaolong Yan ,&nbsp;Zhiqun Lei ,&nbsp;Qi Wang","doi":"10.1016/j.numecd.2024.09.011","DOIUrl":"10.1016/j.numecd.2024.09.011","url":null,"abstract":"<div><h3>Background and aims</h3><div>This study aims to evaluate the impact of ultra-processed food (UPF) on type 2 diabetes (T2D), cardiovascular disease (CVD), hypertension, and cardiometabolic multimorbidity (CMM), and to explore the role of genetic susceptibility in these associations.</div></div><div><h3>Methods and results</h3><div>90 631 participants from the UK Biobank were included (collected between 2006 and 2010). The outcomes assessed included T2D, CVD, hypertension and CMM. The Cox proportional hazards model was used to evaluate their associations and the potential modification by genetic risk, which was estimated using the polygenic risk score (PRS). Participants with high UPF consumption had a higher risk of T2D, CVD, and CMM, with the adjusted hazard ratio (HR) of 1.36 (95 % confidence interval [CI]: 1.15, 1.61), 1.13 (95%CI: 1.03, 1.23), and 1.14 (95%CI: 1.05, 1.24), respectively. Those with high UPF consumption and high PRS for T2D, CVD, and hypertension had the highest risk of T2D (HR: 4.01; 95%CI: 2.83, 5.69), CVD (HR: 2.18; 95%CI: 1.86, 2.56), and hypertension (HR: 1.79; 95%CI: 1.61, 1.99), respectively. In participants with one cardiometabolic disease (CMD), those with high UPF consumption and high PRS<sub>T2D</sub> or PRS<sub>CVD</sub> had the highest risk of developing CMM. A significant additive interaction was observed between PRS<sub>T2D</sub> and UPF consumption on the risk of T2D.</div></div><div><h3>Conclusion</h3><div>Our study underscored the importance of identifying individuals with high UPF consumption for targeted dietary interventions to mitigate the risk of CMDs and CMM, particularly among those with a high genetic risk of CMDs.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"34 12","pages":"Pages 2799-2806"},"PeriodicalIF":3.3,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric acid and risk of incident heart failure in individuals with cardiovascular disease 尿酸与心血管疾病患者发生心力衰竭的风险。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-17 DOI: 10.1016/j.numecd.2024.09.012
Na Li , Yaqi Li , Liufu Cui , Rong Shu , Jiaoyan Li , Haicheng Song , Jierui Wang , Shuohua Chen , Chenrui Zhu , Maoxiang Zhao , Xiang Gao , Tong Liu , Shouling Wu

Background and aims

Uric acid has been positively associated with the risk of developing heart failure in the general population. Nevertheless, it remains unclear whether hyperuricemia is an independent risk factor for heart failure and further contributes to the risk of heart failure among the already at-risk cardiovascular disease (CVD) population. This study aimed to evaluate the association between uric acid and incident heart failure in individuals with established CVD.

Methods and results

Included were 18,438 adults with established CVD but free of heart failure at baseline, from the Kailuan Study. Incident heart failure cases were ascertained by medical records. Cause-specific Cox proportional hazards regression models were applied to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs) of heart failure according to uric acid tertiles. Over a median follow-up of 6.1 years, we identified 1215 incident heart failure cases. Higher uric acid was associated with a higher risk of incident heart failure, with adjusted HR for the last vs. first tertile of 1.50 (95%CI:1.30–1.73). Higher uric acid concentrations were associated with an increased risk of heart failure in individuals with coronary heart disease, atrial fibrillation, and ischemic stroke, but not in those with hemorrhagic stroke. Moreover, the observed association between uric acid and heart failure risk was more pronounced in individuals diagnosed with heart failure with reduced ejection fraction subtype compared with heart failure with preserved ejection fraction.

Conclusions

In individuals with CVD, uric acid was positively associated with the risk of heart failure, in a dose-response manner.
背景和目的:尿酸与普通人群患心力衰竭的风险呈正相关。然而,高尿酸血症是否是心力衰竭的独立风险因素,是否会进一步增加已患心血管疾病(CVD)人群的心力衰竭风险,目前仍不清楚。本研究旨在评估尿酸与已确诊心血管疾病患者发生心力衰竭之间的关系:研究纳入了开滦研究中18,438名已确诊心血管疾病但基线时无心力衰竭的成年人。心力衰竭病例通过医疗记录确定。应用特定病因的考克斯比例危险回归模型,根据尿酸三元组估计心衰的危险比(HRs)和95%置信区间(CIs)。在中位 6.1 年的随访期间,我们共发现了 1215 例心衰病例。尿酸越高,发生心力衰竭的风险越高,最后一个三分位数与第一个三分位数的调整HR值为1.50(95%CI:1.30-1.73)。尿酸浓度较高与冠心病、心房颤动和缺血性中风患者心力衰竭风险增加有关,但与出血性中风患者无关。此外,与射血分数保留型心力衰竭相比,尿酸与心力衰竭风险之间的关联在射血分数降低亚型心力衰竭患者中更为明显:结论:在心血管疾病患者中,尿酸与心力衰竭风险呈剂量反应正相关。
{"title":"Uric acid and risk of incident heart failure in individuals with cardiovascular disease","authors":"Na Li ,&nbsp;Yaqi Li ,&nbsp;Liufu Cui ,&nbsp;Rong Shu ,&nbsp;Jiaoyan Li ,&nbsp;Haicheng Song ,&nbsp;Jierui Wang ,&nbsp;Shuohua Chen ,&nbsp;Chenrui Zhu ,&nbsp;Maoxiang Zhao ,&nbsp;Xiang Gao ,&nbsp;Tong Liu ,&nbsp;Shouling Wu","doi":"10.1016/j.numecd.2024.09.012","DOIUrl":"10.1016/j.numecd.2024.09.012","url":null,"abstract":"<div><h3>Background and aims</h3><div>Uric acid has been positively associated with the risk of developing heart failure in the general population. Nevertheless, it remains unclear whether hyperuricemia is an independent risk factor for heart failure and further contributes to the risk of heart failure among the already at-risk cardiovascular disease (CVD) population. This study aimed to evaluate the association between uric acid and incident heart failure in individuals with established CVD.</div></div><div><h3>Methods and results</h3><div>Included were 18,438 adults with established CVD but free of heart failure at baseline, from the Kailuan Study. Incident heart failure cases were ascertained by medical records. Cause-specific Cox proportional hazards regression models were applied to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs) of heart failure according to uric acid tertiles. Over a median follow-up of 6.1 years, we identified 1215 incident heart failure cases. Higher uric acid was associated with a higher risk of incident heart failure, with adjusted HR for the last vs. first tertile of 1.50 (95%CI:1.30–1.73). Higher uric acid concentrations were associated with an increased risk of heart failure in individuals with coronary heart disease, atrial fibrillation, and ischemic stroke, but not in those with hemorrhagic stroke. Moreover, the observed association between uric acid and heart failure risk was more pronounced in individuals diagnosed with heart failure with reduced ejection fraction subtype compared with heart failure with preserved ejection fraction.</div></div><div><h3>Conclusions</h3><div>In individuals with CVD, uric acid was positively associated with the risk of heart failure, in a dose-response manner.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"34 12","pages":"Pages 2763-2770"},"PeriodicalIF":3.3,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric acid reference values for children and adolescents should be stratified by pubertal stage 儿童和青少年的尿酸参考值应按青春期阶段分层。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-12 DOI: 10.1016/j.numecd.2024.09.009
Shurong Huang , Qifa Hu , Zhuoguang Li , Yanyan Li , Xiu Zhao , Yue Shang , Rongfei Zheng , Qiru Su , Jingfan Xiong , Zhe Su

Background and aim

To establish reference values for hyperuricemia (HUA) in children and adolescents.

Methods and results

The study enrolled 4807 students from “The Evaluation and Monitoring on School-based Nutrition and Growth in Shenzhen study.” Utilizing quantile regression, associations between age, body mass index (BMI), pubertal stage, and serum uric acid (SUA) were examined, alongside the relationship between SUA and cardiovascular disease (CVD) risk factors. Reference values for SUA were explored using receiver operating characteristic analysis, considering sex and pubertal stage. The prevalence of HUA was 34.3 % for boys and 29 % for girls (using the adult HUA diagnostic criteria: >420 μmol/L for males, >360 μmol/L for females), increasing with higher BMI, age, and pubertal stage. Pubertal stage had the largest influence on SUA in boys, while nutritional status was the most significant factor affecting SUA in girls. Adjusting for age and pubertal stage, higher SUA levels correlated with an increased risk of CVD risk factors. Proposed reference values included >360 μmol/L for girls ages 6–17 years and prepubertal boys. For pubertal boys, reference values varied based on age: >392 μmol/L for ages 9–11 in early-middle puberty, >429 μmol/L for ages 12–14 in early-middle puberty, >478 μmol/L for ages 12–14 in late puberty, and >505 μmol/L for ages 15–17 in late puberty.

Conclusions

Stratifying HUA reference values by pubertal stage, particularly for boys, is crucial. Long-term follow-up of individuals with high SUA levels may aid in refining SUA reference values.
背景和目的:确定儿童和青少年高尿酸血症(HUA)的参考值:该研究从 "深圳校本营养与成长评价监测研究 "中招募了 4807 名学生。研究利用量子回归法考察了年龄、体重指数(BMI)、青春期阶段与血清尿酸(SUA)之间的关系,以及SUA与心血管疾病(CVD)风险因素之间的关系。在考虑性别和青春期阶段的情况下,使用接收器操作特征分析法探讨了 SUA 的参考值。男孩的 HUA 患病率为 34.3%,女孩为 29%(采用成人 HUA 诊断标准:男性>420 μmol/L,女性>360 μmol/L),随着体重指数(BMI)、年龄和青春期阶段的增加而增加。青春期阶段对男孩 SUA 的影响最大,而营养状况则是影响女孩 SUA 的最重要因素。调整年龄和青春期阶段后,较高的 SUA 水平与心血管疾病风险因素的增加相关。对于 6-17 岁的女孩和青春期前的男孩,建议的参考值包括 >360 μmol/L。对于青春期男孩,参考值因年龄而异:青春期早中期的 9-11 岁男孩的参考值>392 μmol/L,青春期早中期的 12-14 岁男孩的参考值>429 μmol/L,青春期晚期的 12-14 岁男孩的参考值>478 μmol/L,青春期晚期的 15-17 岁男孩的参考值>505 μmol/L:按青春期阶段划分 HUA 参考值至关重要,尤其是对男孩而言。对 SUA 水平较高的个体进行长期随访有助于完善 SUA 参考值。
{"title":"Uric acid reference values for children and adolescents should be stratified by pubertal stage","authors":"Shurong Huang ,&nbsp;Qifa Hu ,&nbsp;Zhuoguang Li ,&nbsp;Yanyan Li ,&nbsp;Xiu Zhao ,&nbsp;Yue Shang ,&nbsp;Rongfei Zheng ,&nbsp;Qiru Su ,&nbsp;Jingfan Xiong ,&nbsp;Zhe Su","doi":"10.1016/j.numecd.2024.09.009","DOIUrl":"10.1016/j.numecd.2024.09.009","url":null,"abstract":"<div><h3>Background and aim</h3><div>To establish reference values for hyperuricemia (HUA) in children and adolescents.</div></div><div><h3>Methods and results</h3><div>The study enrolled 4807 students from “The Evaluation and Monitoring on School-based Nutrition and Growth in Shenzhen study.” Utilizing quantile regression, associations between age, body mass index (BMI), pubertal stage, and serum uric acid (SUA) were examined, alongside the relationship between SUA and cardiovascular disease (CVD) risk factors. Reference values for SUA were explored using receiver operating characteristic analysis, considering sex and pubertal stage. The prevalence of HUA was 34.3 % for boys and 29 % for girls (using the adult HUA diagnostic criteria: &gt;420 μmol/L for males, &gt;360 μmol/L for females), increasing with higher BMI, age, and pubertal stage. Pubertal stage had the largest influence on SUA in boys, while nutritional status was the most significant factor affecting SUA in girls. Adjusting for age and pubertal stage, higher SUA levels correlated with an increased risk of CVD risk factors. Proposed reference values included &gt;360 μmol/L for girls ages 6–17 years and prepubertal boys. For pubertal boys, reference values varied based on age: &gt;392 μmol/L for ages 9–11 in early-middle puberty, &gt;429 μmol/L for ages 12–14 in early-middle puberty, &gt;478 μmol/L for ages 12–14 in late puberty, and &gt;505 μmol/L for ages 15–17 in late puberty.</div></div><div><h3>Conclusions</h3><div>Stratifying HUA reference values by pubertal stage, particularly for boys, is crucial. Long-term follow-up of individuals with high SUA levels may aid in refining SUA reference values.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"34 12","pages":"Pages 2757-2762"},"PeriodicalIF":3.3,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study 代谢功能障碍相关脂肪肝、肝纤维化与心血管疾病风险:前瞻性队列研究。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-12 DOI: 10.1016/j.numecd.2024.09.001
Ji Woo Baek , Yeun Soo Yang , Keum Ji Jung , Heejin Kimm , So Young Kim , Sunmi Lee , Sun Ha Jee

Background and aims

In patients with NAFLD, liver fibrosis increases liver-related complications, but there is controversy about the increase in CVD. Based on a prospective cohort study, this study investigated the risk of cardiovascular disease due to liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

Methods and results

This study analyzed KCPS-II prospective cohort that tracked 104,399 people who participated in health check-ups at 18 institutions nationwide from 2004 to 2013. If the fatty liver index was 30 or higher, it was defined as SLD, and participants were classified into No-SLD, MASLD, MetALD, ALD, and Cryptogenic SLD. Liver fibrosis was defined by the FIB-4 index, and the occurrence of cardiovascular disease according to SLD classification was analyzed using Cox proportional model regression analysis. Out study included a total of 6,942 participants (6.6%) had MASLD, 6,694 (6.4%) had MetALD, 4,751 (4.6%) had ALD, and 382 (0.3%) had Cryptogenic SLD. For the cases of FIB-4 index ≥1.3, the multivariable-adjusted HR (95% CI) of cardiovascular disease was 2.27 (1.87-2–76) in MASLD, 1.67 (1.30–2.10) in MetALD, and 2.56 (1.99–3.30) in ALD, but it was 0.78 (0.19–3.10) in Cryptogenic_SLD, which was not significant. The risk of cardiovascular disease according to the fibrosis stage classified by BARD also presented similar results.

Conclusions

This prospective cohort study of Korean patients with newly defined MASLD, MetALD, and ALD with FIB-4 ≥ 1.3 at high risk of developing cardiovascular disease.
背景和目的:在非酒精性脂肪肝患者中,肝纤维化会增加肝脏相关并发症,但对于心血管疾病的增加存在争议。本研究基于一项前瞻性队列研究,调查了代谢功能障碍相关性脂肪性肝病(MASLD)患者肝纤维化导致心血管疾病的风险:本研究分析了KCPS-II前瞻性队列,该队列追踪了2004年至2013年期间在全国18家机构参加健康体检的104399人。如果脂肪肝指数达到或超过 30,则被定义为 SLD,参与者被分为无 SLD、MASLD、MetALD、ALD 和隐源性 SLD。肝纤维化由 FIB-4 指数定义,心血管疾病的发生率则根据 SLD 分类采用 Cox 比例模型回归分析法进行分析。研究共纳入了6942名(6.6%)患有MASLD的参与者,6694名(6.4%)患有MetALD的参与者,4751名(4.6%)患有ALD的参与者,382名(0.3%)患有隐源性SLD的参与者。对于FIB-4指数≥1.3的病例,经多变量调整后,MASLD的心血管疾病HR(95% CI)为2.27(1.87-2-76),MetALD为1.67(1.30-2.10),ALD为2.56(1.99-3.30),而隐源性SLD为0.78(0.19-3.10),差异不显著。根据BARD划分的纤维化阶段得出的心血管疾病风险也呈现出相似的结果:这项前瞻性队列研究的对象是FIB-4≥1.3的新定义的MASLD、MetALD和ALD韩国患者,他们罹患心血管疾病的风险很高。
{"title":"Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study","authors":"Ji Woo Baek ,&nbsp;Yeun Soo Yang ,&nbsp;Keum Ji Jung ,&nbsp;Heejin Kimm ,&nbsp;So Young Kim ,&nbsp;Sunmi Lee ,&nbsp;Sun Ha Jee","doi":"10.1016/j.numecd.2024.09.001","DOIUrl":"10.1016/j.numecd.2024.09.001","url":null,"abstract":"<div><h3>Background and aims</h3><div>In patients with NAFLD, liver fibrosis increases liver-related complications, but there is controversy about the increase in CVD. Based on a prospective cohort study, this study investigated the risk of cardiovascular disease due to liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).</div></div><div><h3>Methods and results</h3><div>This study analyzed KCPS-II prospective cohort that tracked 104,399 people who participated in health check-ups at 18 institutions nationwide from 2004 to 2013. If the fatty liver index was 30 or higher, it was defined as SLD, and participants were classified into No-SLD, MASLD, MetALD, ALD, and Cryptogenic SLD. Liver fibrosis was defined by the FIB-4 index, and the occurrence of cardiovascular disease according to SLD classification was analyzed using Cox proportional model regression analysis. Out study included a total of 6,942 participants (6.6%) had MASLD, 6,694 (6.4%) had MetALD, 4,751 (4.6%) had ALD, and 382 (0.3%) had Cryptogenic SLD. For the cases of FIB-4 index ≥1.3, the multivariable-adjusted HR (95% CI) of cardiovascular disease was 2.27 (1.87-2–76) in MASLD, 1.67 (1.30–2.10) in MetALD, and 2.56 (1.99–3.30) in ALD, but it was 0.78 (0.19–3.10) in Cryptogenic_SLD, which was not significant. The risk of cardiovascular disease according to the fibrosis stage classified by BARD also presented similar results.</div></div><div><h3>Conclusions</h3><div>This prospective cohort study of Korean patients with newly defined MASLD, MetALD, and ALD with FIB-4 ≥ 1.3 at high risk of developing cardiovascular disease.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"34 12","pages":"Pages 2623-2629"},"PeriodicalIF":3.3,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142570274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low triiodothyronine is associated with high risk of malnutrition and poor functional status in subacute stroke patients. 三碘甲状腺原氨酸低与亚急性脑卒中患者营养不良和功能状况不佳的高风险相关。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-12 DOI: 10.1016/j.numecd.2024.09.008
Olivia Di Vincenzo, Ermenegilda Pagano, Mariarosaria Cervone, Lucia Acampora, Monica Dentice, Chiara Francesca Gheri, Fabrizio Pasanisi, Luca Scalfi

Background and aims: Stroke patients may exhibit low thyroid hormone (TH) levels and disease-related malnutrition, both potentially affecting clinical status; their relationships remain unexplored. This study aimed to evaluate TH concentrations in subacute stroke patients and investigate the relationships between TH levels, nutritional risk, and functional status.

Methods and results: Early subacute stroke patients admitted to a rehabilitation unit were assessed using various nutritional screening tools (Geriatric Nutritional Risk Index-GNRI, Prognostic Nutritional Index-PNI, and Controlling Nutritional Status-CONUT score) and with the Global Leadership Initiative on Malnutrition (GLIM) criteria. Thyroid-Stimulating Hormone (TSH), free Tetraiodothyronine-Thyroxine (fT4) and free Triiodothyronine (fT3) levels were determined. Functional and cognitive status was evaluated using different scales. Associations between altered THs and nutritional status were examined through univariate/multivariate analyses and ROC analyses. Among 264 patients (age 72.0 ± 10.5 yrs), significant correlations emerged between fT3 and nutritional risk and functional tests (mostly p < 0.001). The prevalence of high nutritional risk determined by GNRI, PNI and CONUT increased from higher to lower fT3 tertiles. Lower fT3 levels were observed in patients at high nutritional risk and with GLIM-based malnutrition. fT3 exhibited reasonable predictive power for high nutritional risk (particularly PNI: AUC 0.769, 95%CI 0.702-0.836, p < 0.001). Multivariate logistic regression identified nutritional risk (p < 0.001) and time from stroke onset as predictors of low fT3 values.

Conclusion: Altered fT3 levels in early subacute stroke patients correlate with high nutritional risk and poor functional status. Low fT3 values upon admission for stroke rehabilitation may serve as a further parameter to be considered in patients at high nutritional risk.

背景和目的:脑卒中患者可能表现出甲状腺激素(TH)水平低和与疾病相关的营养不良,这两种情况都可能影响临床状态;但它们之间的关系仍未得到探讨。本研究旨在评估亚急性脑卒中患者的甲状腺激素浓度,并探讨甲状腺激素水平、营养风险和功能状态之间的关系:使用各种营养筛查工具(老年营养风险指数(Geriatric Nutritional Risk Index-GNRI)、预后营养指数(Prognostic Nutritional Index-PNI)和营养状况控制评分(Controlling Nutritional Status-CONUT score))和全球营养不良领导倡议(GLIM)标准对入住康复科的早期亚急性脑卒中患者进行评估。测定了促甲状腺激素(TSH)、游离四碘甲状腺原氨酸-甲状腺素(fT4)和游离三碘甲状腺原氨酸(fT3)水平。使用不同的量表对患者的功能和认知状况进行了评估。通过单变量/多变量分析和 ROC 分析研究了 THs 变化与营养状况之间的关系。在 264 名患者(年龄为 72.0 ± 10.5 岁)中,fT3 与营养风险和功能测试之间存在显著相关性(大部分为 p 结论:fT3 与营养风险和功能测试之间存在显著相关性:早期亚急性脑卒中患者的 fT3 水平变化与营养风险高和功能状态差相关。脑卒中康复入院时的低 fT3 值可作为高营养风险患者的另一个考虑参数。
{"title":"Low triiodothyronine is associated with high risk of malnutrition and poor functional status in subacute stroke patients.","authors":"Olivia Di Vincenzo, Ermenegilda Pagano, Mariarosaria Cervone, Lucia Acampora, Monica Dentice, Chiara Francesca Gheri, Fabrizio Pasanisi, Luca Scalfi","doi":"10.1016/j.numecd.2024.09.008","DOIUrl":"https://doi.org/10.1016/j.numecd.2024.09.008","url":null,"abstract":"<p><strong>Background and aims: </strong>Stroke patients may exhibit low thyroid hormone (TH) levels and disease-related malnutrition, both potentially affecting clinical status; their relationships remain unexplored. This study aimed to evaluate TH concentrations in subacute stroke patients and investigate the relationships between TH levels, nutritional risk, and functional status.</p><p><strong>Methods and results: </strong>Early subacute stroke patients admitted to a rehabilitation unit were assessed using various nutritional screening tools (Geriatric Nutritional Risk Index-GNRI, Prognostic Nutritional Index-PNI, and Controlling Nutritional Status-CONUT score) and with the Global Leadership Initiative on Malnutrition (GLIM) criteria. Thyroid-Stimulating Hormone (TSH), free Tetraiodothyronine-Thyroxine (fT4) and free Triiodothyronine (fT3) levels were determined. Functional and cognitive status was evaluated using different scales. Associations between altered THs and nutritional status were examined through univariate/multivariate analyses and ROC analyses. Among 264 patients (age 72.0 ± 10.5 yrs), significant correlations emerged between fT3 and nutritional risk and functional tests (mostly p < 0.001). The prevalence of high nutritional risk determined by GNRI, PNI and CONUT increased from higher to lower fT3 tertiles. Lower fT3 levels were observed in patients at high nutritional risk and with GLIM-based malnutrition. fT3 exhibited reasonable predictive power for high nutritional risk (particularly PNI: AUC 0.769, 95%CI 0.702-0.836, p < 0.001). Multivariate logistic regression identified nutritional risk (p < 0.001) and time from stroke onset as predictors of low fT3 values.</p><p><strong>Conclusion: </strong>Altered fT3 levels in early subacute stroke patients correlate with high nutritional risk and poor functional status. Low fT3 values upon admission for stroke rehabilitation may serve as a further parameter to be considered in patients at high nutritional risk.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dental caries and adolescent cardiometabolic health from the National Health and Nutrition Examination Survey (NHANES). 全国健康与营养调查(NHANES)中的龋齿与青少年心脏代谢健康。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/j.numecd.2024.09.006
Kristal Wong, Srighana Nadella, Mel Mupparapu, Christine Sethna

Background and aims: To assess the association between dental caries and cardiometabolic risk in adolescents.

Methods and results: The analysis included adolescents aged 13-17 years enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 who completed an Oral Health Examination. Untreated caries was defined as having one or more decayed teeth. Caries experience was assessed by Decayed, Missing, Filled Teeth (DMFT) score. Primary cardiometabolic outcomes included elevated BP (defined as BP 120-129/<80 mmHg) and hypertensive BP (defined as BP ≥ 130/80 mmHg). Secondary cardiometabolic outcomes included obesity, dyslipidemia (defined as any abnormal lipid level), glucose intolerance (measured by HOMA-IR), and microalbuminuria (defined as urine albumin: creatinine ≥30 mg/mg). Adjusted linear and logistic models examined associations using complex survey design procedures. In the sample of 2861 adolescents, 25.6 % (1.3 %) had untreated caries. 55.4 % (1.3 %) had DMFT ≥1. In adjusted regression analyses, untreated caries status was not significantly associated with primary outcomes of elevated BP (OR = 1.04, 95 % CI 0.71, 1.52 p > 0.05), hypertensive BP (OR = 1.72, 95 % CI 0.71, 3.89 p > 0.05), nor secondary cardiometabolic outcomes. No statistically significant associations were found between DMFT score and primary outcomes of elevated BP (OR = 0.01, 95 % CI 0.34, 1.07 p > 0.05), hypertensive BP (OR = 0.91, 95 % CI 0.81, 1.08 p > 0.05), or secondary cardiometabolic outcomes.

Conclusion: Although studies in other countries and in adults show associations between caries and cardiometabolic outcomes, this study did not find an association between caries and cardiometabolic markers.

背景与目的评估青少年龋齿与心脏代谢风险之间的关联:分析对象包括2011年至2018年参加美国国家健康与营养调查(NHANES)并完成口腔健康检查的13-17岁青少年。未经治疗的龋齿被定义为有一颗或多颗蛀牙。龋齿情况通过蛀牙、缺失牙、填充牙(DMFT)评分进行评估。主要心脏代谢结果包括血压升高(定义为血压 120-129/ 0.05)、高血压(OR = 1.72,95 % CI 0.71,3.89 p > 0.05)或继发性心脏代谢结果。DMFT 评分与血压升高(OR = 0.01,95 % CI 0.34,1.07 p > 0.05)、高血压(OR = 0.91,95 % CI 0.81,1.08 p > 0.05)或继发性心脏代谢结果等主要结果之间没有统计学意义:尽管其他国家和成人的研究显示龋齿与心脏代谢结果之间存在关联,但本研究并未发现龋齿与心脏代谢指标之间存在关联。
{"title":"Dental caries and adolescent cardiometabolic health from the National Health and Nutrition Examination Survey (NHANES).","authors":"Kristal Wong, Srighana Nadella, Mel Mupparapu, Christine Sethna","doi":"10.1016/j.numecd.2024.09.006","DOIUrl":"https://doi.org/10.1016/j.numecd.2024.09.006","url":null,"abstract":"<p><strong>Background and aims: </strong>To assess the association between dental caries and cardiometabolic risk in adolescents.</p><p><strong>Methods and results: </strong>The analysis included adolescents aged 13-17 years enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 who completed an Oral Health Examination. Untreated caries was defined as having one or more decayed teeth. Caries experience was assessed by Decayed, Missing, Filled Teeth (DMFT) score. Primary cardiometabolic outcomes included elevated BP (defined as BP 120-129/<80 mmHg) and hypertensive BP (defined as BP ≥ 130/80 mmHg). Secondary cardiometabolic outcomes included obesity, dyslipidemia (defined as any abnormal lipid level), glucose intolerance (measured by HOMA-IR), and microalbuminuria (defined as urine albumin: creatinine ≥30 mg/mg). Adjusted linear and logistic models examined associations using complex survey design procedures. In the sample of 2861 adolescents, 25.6 % (1.3 %) had untreated caries. 55.4 % (1.3 %) had DMFT ≥1. In adjusted regression analyses, untreated caries status was not significantly associated with primary outcomes of elevated BP (OR = 1.04, 95 % CI 0.71, 1.52 p > 0.05), hypertensive BP (OR = 1.72, 95 % CI 0.71, 3.89 p > 0.05), nor secondary cardiometabolic outcomes. No statistically significant associations were found between DMFT score and primary outcomes of elevated BP (OR = 0.01, 95 % CI 0.34, 1.07 p > 0.05), hypertensive BP (OR = 0.91, 95 % CI 0.81, 1.08 p > 0.05), or secondary cardiometabolic outcomes.</p><p><strong>Conclusion: </strong>Although studies in other countries and in adults show associations between caries and cardiometabolic outcomes, this study did not find an association between caries and cardiometabolic markers.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Basal and post-stress ceramide-based risk score CERT1 predicts all-cause mortality and nonfatal myocardial infarction in patients with suspected or established coronary artery disease undergoing stress myocardial perfusion scintigraphy. 基于神经酰胺的基础和应激后风险评分 CERT1 可预测接受应激心肌灌注闪烁成像检查的疑似或已确诊冠心病患者的全因死亡率和非致命性心肌梗死。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/j.numecd.2024.09.005
Alessandro Mantovani, Agustin E Molinero, Stefano Bonapace, Gianluigi Lunardi, Matteo Salgarello, Riccardo Morandin, Francesca Moretta, Antonio Conti, Giulio Molon, Reijo Laaksonen, Christopher D Byrne, Giovanni Targher

Background and aim: We examined whether a plasma ceramide-based risk score (CERT1 score), a newly proposed tool for cardiovascular risk prediction, is associated with an increased risk of all-cause mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease (CAD).

Methods and results: We studied 167 ambulatory patients who consecutively underwent stress myocardial perfusion scintigraphy (MPS) for clinical reasons in 2017 (at baseline) and then followed for a median of 6 years (inter-quartile range: 4.7-6.6 years). For the calculation of the CERT1 score, both before and after stress MPS, we measured three specific plasma ceramide concentrations [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratio to Cer(d18:1/24:0) using a targeted liquid chromatography-tandem mass spectrometry assay. The primary outcome of the study was a composite of all-cause mortality or nonfatal myocardial infarction. During a median of 6 years, a total of 50 events occurred (26 all-cause deaths and 24 nonfatal myocardial infarctions). There was a significant association between pre-stress CERT1 risk categories (high vs. low risk) at baseline and the risk of developing the primary composite outcome (unadjusted HR 1.78, 95% CI 1.02-3.14). This risk remained significant after adjustment for age, sex, smoking, diabetes, pre-existing CAD, left ventricular ejection fraction, and stress-induced inducible myocardial ischemia on MPS (adjusted HR 2.28, 95% CI 1.17-4.41, p = 0.015). Almost identical results were observed for post-stress CERT1 risk categories.

Conclusions: Pre-stress and post-stress CERT1 high-risk categories at baseline were strongly associated with an increased long-term risk of all-cause mortality or nonfatal myocardial infarction in patients with suspected or established CAD.

背景和目的:我们研究了基于血浆神经酰胺的风险评分(CERT1评分)--一种新提出的心血管风险预测工具--是否与疑似或已知冠状动脉疾病(CAD)患者全因死亡率和非致死性心肌梗死风险的增加有关:我们对 167 名门诊患者进行了研究,这些患者在 2017 年(基线时)因临床原因连续接受了应激心肌灌注闪烁成像(MPS),然后随访了中位数 6 年(四分位间范围:4.7-6.6 年)。为了计算应激MPS前后的CERT1得分,我们使用靶向液相色谱-串联质谱测定法测量了三种特定的血浆神经酰胺浓度[Cer(d18:1/16:0)、Cer(d18:1/18:0)和Cer(d18:1/24:1)]及其与Cer(d18:1/24:0)的比值。研究的主要结果是全因死亡率或非致死性心肌梗死的综合结果。在中位 6 年的时间里,共发生了 50 起事件(26 起全因死亡和 24 起非致命性心肌梗死)。基线压力前的 CERT1 风险类别(高风险与低风险)与主要复合结果的发生风险之间存在明显关联(未调整 HR 1.78,95% CI 1.02-3.14)。在对年龄、性别、吸烟、糖尿病、原有 CAD、左心室射血分数和 MPS 压力诱导性心肌缺血进行调整后,该风险仍然显著(调整后 HR 2.28,95% CI 1.17-4.41,p = 0.015)。应激后CERT1风险类别的结果几乎相同:结论:在疑似或已确诊为 CAD 的患者中,压力前和压力后的基线 CERT1 高风险类别与全因死亡率或非致死性心肌梗死的长期风险增加密切相关。
{"title":"Basal and post-stress ceramide-based risk score CERT1 predicts all-cause mortality and nonfatal myocardial infarction in patients with suspected or established coronary artery disease undergoing stress myocardial perfusion scintigraphy.","authors":"Alessandro Mantovani, Agustin E Molinero, Stefano Bonapace, Gianluigi Lunardi, Matteo Salgarello, Riccardo Morandin, Francesca Moretta, Antonio Conti, Giulio Molon, Reijo Laaksonen, Christopher D Byrne, Giovanni Targher","doi":"10.1016/j.numecd.2024.09.005","DOIUrl":"https://doi.org/10.1016/j.numecd.2024.09.005","url":null,"abstract":"<p><strong>Background and aim: </strong>We examined whether a plasma ceramide-based risk score (CERT1 score), a newly proposed tool for cardiovascular risk prediction, is associated with an increased risk of all-cause mortality and nonfatal myocardial infarction in patients with suspected or known coronary artery disease (CAD).</p><p><strong>Methods and results: </strong>We studied 167 ambulatory patients who consecutively underwent stress myocardial perfusion scintigraphy (MPS) for clinical reasons in 2017 (at baseline) and then followed for a median of 6 years (inter-quartile range: 4.7-6.6 years). For the calculation of the CERT1 score, both before and after stress MPS, we measured three specific plasma ceramide concentrations [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratio to Cer(d18:1/24:0) using a targeted liquid chromatography-tandem mass spectrometry assay. The primary outcome of the study was a composite of all-cause mortality or nonfatal myocardial infarction. During a median of 6 years, a total of 50 events occurred (26 all-cause deaths and 24 nonfatal myocardial infarctions). There was a significant association between pre-stress CERT1 risk categories (high vs. low risk) at baseline and the risk of developing the primary composite outcome (unadjusted HR 1.78, 95% CI 1.02-3.14). This risk remained significant after adjustment for age, sex, smoking, diabetes, pre-existing CAD, left ventricular ejection fraction, and stress-induced inducible myocardial ischemia on MPS (adjusted HR 2.28, 95% CI 1.17-4.41, p = 0.015). Almost identical results were observed for post-stress CERT1 risk categories.</p><p><strong>Conclusions: </strong>Pre-stress and post-stress CERT1 high-risk categories at baseline were strongly associated with an increased long-term risk of all-cause mortality or nonfatal myocardial infarction in patients with suspected or established CAD.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of early postnatal overnutrition on cardiac mitochondrial dysfunction in adult mice with ischemia/reperfusion. 出生后早期营养过剩对缺血/再灌注成年小鼠心脏线粒体功能障碍的影响
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/j.numecd.2024.09.007
Anatalia K G Vieira, Amélia F Bernardo, Fabiana A Neves, Vivian M Soares, Roberta M Guedes, Patrícia N Soares, Patrícia C Lisboa, Erika Cortez, Egberto G Moura, Bruna G da Silva, Erica P Garcia-Souza, Anibal S Moura

Background and aims: Nutritional imbalance at the beginning of life, a critical window period, leads to the development of obesity, overweight, dyslipidemia, diabetes, and cardiovascular disease in adulthood. In this study, the effects and associations of overnutrition during lactation on energy metabolism and oxidative stress in cardiomyocytes of adult male Swiss mice were examined.

Methods and results: Animals were divided into two groups (control and overfed) subjected to baseline and ischemia/reperfusion conditions, forming four groups: control baseline (CBL), control ischemia/reperfusion (CIR), overfed baseline (OBL), and overfed ischemia/reperfusion (OIR). The hearts were analyzed for hemodynamics using the Langendorff technique, mitochondrial energy metabolism using the Oroboros apparatus, ATP production, oxidative stress, and SIRT1, pSTAT3 and STAT3 protein content by Western blotting. Hemodynamic abnormalities in the cardiovascular system were associated with mitochondrial dysfunction, as demonstrated by impaired carbohydrate and fatty acid oxidation capacity, decreased mitochondrial coupling in the OG, and reduced ATP production in the OIR group. Alteration in pSTAT3 and SIRT1 proteins expression in overfed mice reinforce energy metabolism impairment. Lipid and/or protein degradation is altered in the heart of OG, suggesting increased oxidative stress.

Conclusion: Overnutrition during lactation associated with heart ischemia leads to molecular cardiac alterations in STAT3 and SIRT1 proteins, compromising energy metabolism via reduced mitochondrial oxidation capacity, ATP production and increased lipid peroxidation.

背景和目的:生命之初的营养失衡是一个关键的窗口期,会导致成年后肥胖、超重、血脂异常、糖尿病和心血管疾病的发生。本研究探讨了哺乳期营养过剩对成年雄性瑞士小鼠心肌细胞能量代谢和氧化应激的影响及相关性:将动物分为两组(对照组和过度饲养组),分别进行基线和缺血/再灌注试验,形成四组:对照基线组(CBL)、对照缺血/再灌注组(CIR)、过度饲养基线组(OBL)和过度饲养缺血/再灌注组(OIR)。使用朗根多夫技术分析了心脏的血液动力学,使用奥罗伯罗斯仪器分析了线粒体的能量代谢、ATP产生、氧化应激,并通过Western印迹分析了SIRT1、pSTAT3和STAT3蛋白含量。心血管系统的血流动力学异常与线粒体功能障碍有关,表现为碳水化合物和脂肪酸氧化能力受损,OG 组线粒体耦合能力下降,OIR 组 ATP 生成减少。过度喂养小鼠中 pSTAT3 和 SIRT1 蛋白表达的改变加剧了能量代谢的障碍。OG心脏中脂质和/或蛋白质降解发生改变,表明氧化应激增加:结论:与心脏缺血相关的哺乳期营养过剩会导致STAT3和SIRT1蛋白在心脏中的分子改变,通过降低线粒体氧化能力、ATP生成和增加脂质过氧化来损害能量代谢。
{"title":"Impact of early postnatal overnutrition on cardiac mitochondrial dysfunction in adult mice with ischemia/reperfusion.","authors":"Anatalia K G Vieira, Amélia F Bernardo, Fabiana A Neves, Vivian M Soares, Roberta M Guedes, Patrícia N Soares, Patrícia C Lisboa, Erika Cortez, Egberto G Moura, Bruna G da Silva, Erica P Garcia-Souza, Anibal S Moura","doi":"10.1016/j.numecd.2024.09.007","DOIUrl":"https://doi.org/10.1016/j.numecd.2024.09.007","url":null,"abstract":"<p><strong>Background and aims: </strong>Nutritional imbalance at the beginning of life, a critical window period, leads to the development of obesity, overweight, dyslipidemia, diabetes, and cardiovascular disease in adulthood. In this study, the effects and associations of overnutrition during lactation on energy metabolism and oxidative stress in cardiomyocytes of adult male Swiss mice were examined.</p><p><strong>Methods and results: </strong>Animals were divided into two groups (control and overfed) subjected to baseline and ischemia/reperfusion conditions, forming four groups: control baseline (CBL), control ischemia/reperfusion (CIR), overfed baseline (OBL), and overfed ischemia/reperfusion (OIR). The hearts were analyzed for hemodynamics using the Langendorff technique, mitochondrial energy metabolism using the Oroboros apparatus, ATP production, oxidative stress, and SIRT1, pSTAT3 and STAT3 protein content by Western blotting. Hemodynamic abnormalities in the cardiovascular system were associated with mitochondrial dysfunction, as demonstrated by impaired carbohydrate and fatty acid oxidation capacity, decreased mitochondrial coupling in the OG, and reduced ATP production in the OIR group. Alteration in pSTAT3 and SIRT1 proteins expression in overfed mice reinforce energy metabolism impairment. Lipid and/or protein degradation is altered in the heart of OG, suggesting increased oxidative stress.</p><p><strong>Conclusion: </strong>Overnutrition during lactation associated with heart ischemia leads to molecular cardiac alterations in STAT3 and SIRT1 proteins, compromising energy metabolism via reduced mitochondrial oxidation capacity, ATP production and increased lipid peroxidation.</p>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: A scoping review 改善心脏代谢疾病预防和管理护理的组织举措:范围综述。
IF 3.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/j.numecd.2024.09.004
Hellena Hailu Habte-Asres , Chuyou Hou , Angus Forbes , David C. Wheeler

Aim

Cardiometabolic conditions such as cardiovascular disease, type 2 diabetes, and chronic kidney disease contribute to multimorbidity, posing a global health challenge. However, existing healthcare frameworks often struggle to adequately address the intricate needs of individuals living with these conditions. The review aims to map existing research on cardiometabolic care initiatives for the primary and secondary prevention of metabolic conditions.

Data synthesis

A scoping review was conducted following the methodology of the Joanna-Briggs-Institute. We searched Medline, Embase, and CINAHL. The review primarily sought studies comparing the effectiveness of cardiometabolic services/clinics in primary or secondary prevention of cardiometabolic conditions with standard care. The data from these studies were charted and summarised in tabular form, with a narrative synthesis.
The search identified 97 records across three databases, and 18 documents met inclusion criteria. Two studies addressed cardiometabolic care in primary prevention, while twelve focused on secondary prevention. Positive outcomes were observed in primary prevention, including reductions in waist circumference, body mass index, blood pressure, and cholesterol levels. For secondary prevention, the studies demonstrated positive metabolic outcomes, such as reductions in HbA1c, weight, blood pressure, and cholesterol levels. Additionally, data from the available studies reported improved adherence to diabetes care processes and the implementation of guideline-directed therapies.

Conclusion

This scoping review highlights the potential benefits of services such as cardiometabolic clinics for primary and secondary prevention in metabolic conditions. Future studies should use standardised outcome measures and include details on the structure, staffing and treatment intensity of clinics to aid their wider implementation.
目的:心血管疾病、2 型糖尿病和慢性肾病等心脏代谢疾病导致多病并发,对全球健康构成挑战。然而,现有的医疗保健框架往往难以充分满足这些疾病患者的复杂需求。本综述旨在梳理有关心脏代谢护理措施的现有研究,以便对代谢疾病进行一级和二级预防:我们按照乔安娜-布里格斯研究所(Joanna-Briggs-Institute)的方法进行了范围界定综述。我们检索了 Medline、Embase 和 CINAHL。该综述主要寻求将心脏代谢服务/诊所在心脏代谢疾病一级或二级预防中的有效性与标准护理进行比较的研究。这些研究的数据以图表形式进行了记录和总结,并进行了叙述性综合。搜索结果在三个数据库中发现了 97 条记录,其中 18 篇文献符合纳入标准。其中两项研究涉及一级预防中的心脏代谢护理,十二项研究侧重于二级预防。在一级预防中观察到了积极的结果,包括腰围、体重指数、血压和胆固醇水平的降低。在二级预防方面,研究显示了积极的代谢结果,如 HbA1c、体重、血压和胆固醇水平的降低。此外,现有研究数据还显示,糖尿病护理流程的依从性和指南指导疗法的实施情况均有所改善:本范围综述强调了心脏代谢门诊等服务对代谢疾病一级和二级预防的潜在益处。未来的研究应使用标准化的结果测量方法,并详细介绍诊所的结构、人员配备和治疗强度,以帮助其更广泛地实施。
{"title":"Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: A scoping review","authors":"Hellena Hailu Habte-Asres ,&nbsp;Chuyou Hou ,&nbsp;Angus Forbes ,&nbsp;David C. Wheeler","doi":"10.1016/j.numecd.2024.09.004","DOIUrl":"10.1016/j.numecd.2024.09.004","url":null,"abstract":"<div><h3>Aim</h3><div>Cardiometabolic conditions such as cardiovascular disease, type 2 diabetes, and chronic kidney disease contribute to multimorbidity, posing a global health challenge. However, existing healthcare frameworks often struggle to adequately address the intricate needs of individuals living with these conditions. The review aims to map existing research on cardiometabolic care initiatives for the primary and secondary prevention of metabolic conditions.</div></div><div><h3>Data synthesis</h3><div>A scoping review was conducted following the methodology of the Joanna-Briggs-Institute. We searched Medline, Embase, and CINAHL. The review primarily sought studies comparing the effectiveness of cardiometabolic services/clinics in primary or secondary prevention of cardiometabolic conditions with standard care. The data from these studies were charted and summarised in tabular form, with a narrative synthesis.</div><div>The search identified 97 records across three databases, and 18 documents met inclusion criteria. Two studies addressed cardiometabolic care in primary prevention, while twelve focused on secondary prevention. Positive outcomes were observed in primary prevention, including reductions in waist circumference, body mass index, blood pressure, and cholesterol levels. For secondary prevention, the studies demonstrated positive metabolic outcomes, such as reductions in HbA1c, weight, blood pressure, and cholesterol levels. Additionally, data from the available studies reported improved adherence to diabetes care processes and the implementation of guideline-directed therapies.</div></div><div><h3>Conclusion</h3><div>This scoping review highlights the potential benefits of services such as cardiometabolic clinics for primary and secondary prevention in metabolic conditions. Future studies should use standardised outcome measures and include details on the structure, staffing and treatment intensity of clinics to aid their wider implementation.</div></div>","PeriodicalId":49722,"journal":{"name":"Nutrition Metabolism and Cardiovascular Diseases","volume":"34 12","pages":"Pages 2630-2641"},"PeriodicalIF":3.3,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nutrition Metabolism and Cardiovascular Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1